Platelet receptor polymorphisms and thrombotic risk
Platelet receptor polymorphisms and thrombotic risk
First risk functions for prediction of coronary and cardiovascular disease incidence in the Gubbio Population Study
First risk functions for prediction of coronary and cardiovascular disease incidence in the Gubbio Population Study
Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge?
Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge?